Equities

Tauns Laboratories Inc

197A:TYO

Tauns Laboratories Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)569.00
  • Today's Change-6.00 / -1.04%
  • Shares traded784.50k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.

  • Revenue in JPY (TTM)18.43bn
  • Net income in JPY5.77bn
  • Incorporated2016
  • Employees271.00
  • Location
    Tauns Laboratories Inc761-1, KamishimaIZUNOKUNI-SHI 410-2325JapanJPN
  • Phone+81 558768181
  • Fax+81 558760022
  • Websitehttps://www.tauns.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rion Co Ltd26.67bn2.59bn30.57bn1.03k11.771.018.331.15210.52210.522,165.882,443.260.72271.734.1225,990,020.007.036.278.177.2550.4050.299.728.852.41----28.117.793.8647.395.7825.244.56
Mizuho Medy Co Ltd10.99bn3.50bn30.71bn180.008.781.908.262.79183.56183.56576.85846.830.59721.692.6061,046,260.0019.0131.4621.2539.7871.8874.8531.8333.647.62--0.0034.83-37.4911.34-51.8532.64-17.7432.85
Nippon Care Supply Co., Ltd.30.49bn1.67bn30.74bn1.33k17.581.813.701.01107.69107.691,962.131,045.341.21119.7527.3122,853,900.006.657.619.629.9435.2037.585.496.780.6264--0.160556.7510.4310.474.212.0724.048.76
Win-Partners Co Ltd80.84bn1.98bn38.68bn629.0018.301.5917.710.478569.2969.292,830.28798.131.8824.194.87128,518,700.004.604.398.318.0612.2812.502.452.681.68----63.188.762.01-10.33-7.0140.619.34
France Bed Holdings Co Ltd60.04bn3.21bn47.61bn1.78k14.021.115.480.793188.4888.481,653.981,114.400.9223.166.3533,670,780.004.933.856.335.2454.1452.365.354.412.01--0.260549.980.97822.7015.993.81-1.019.30
Medikit Co Ltd22.29bn3.03bn52.03bn966.0014.740.965111.762.33197.42197.421,453.363,015.350.41923.584.2923,074,350.005.695.756.406.3138.7540.0513.5814.084.774,935.020.0038.881.133.387.153.56-0.600512.20
CI Medical Co Ltd47.75bn1.43bn52.50bn473.0036.632.5715.651.1028.6628.66955.00408.471.164.2814.43100,945,000.003.5510.837.1915.6525.7327.733.066.060.524200.360.483512.836.3812.07-17.419.3877.2413.65
TAUNS Laboratories Inc18.43bn5.77bn58.00bn271.009.964.218.993.1557.7457.74184.35136.67------68,025,330.00--------67.80--31.32--1.16341.330.4111--17.62--90.26------
Japan Eyewear Holdings Co Ltd15.43bn3.01bn63.80bn542.0021.334.3613.924.14124.12124.12637.46607.450.45652.1913.2528,459,410.008.90--10.18--78.21--19.50--1.1810.040.5285--26.17--659.25------
Shofu Inc37.52bn4.46bn74.83bn1.37k16.711.7918.291.99125.14125.141,052.791,168.620.79511.449.4927,406,870.009.486.1510.627.0059.7157.7611.928.122.89--0.004831.8410.747.0816.5924.935.0321.94
Intermestic Inc-100.00bn-100.00bn77.63bn1.84k--7.28----------348.56------------------------1.10--0.494--11.12--102.26------
Nagaileben Co., Ltd.16.41bn2.82bn79.48bn511.0025.041.6433.204.8488.8088.80516.261,355.910.34881.483.29--6.007.326.437.9242.8344.5817.1919.7110.20----57.20-4.48-0.4484-12.53-3.91-6.530.00
Eiken Chemical Co Ltd39.52bn2.33bn83.60bn757.0033.511.6225.632.1264.7264.721,103.441,339.120.60992.743.3052,202,110.003.598.014.4110.1441.2345.925.8811.502.13--0.060835.45-7.442.29-54.08-5.2411.6611.20
Data as of Nov 15 2024. Currency figures normalised to Tauns Laboratories Inc's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.